We are live on
!
Find out more
TRIM
Thompson Rubinstein Investment Management Portfolio holdings
AUM
$311M
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.74%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.77%
5 Year Est. Return
+48.6%
10 Year Est. Return
–
AUM
$261M
AUM Growth
+$6.96M
(+2.7%)
Cap. Flow
+$946K
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
39.48%
Holding
75
New
5
Increased
17
Reduced
28
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DO
Diamond Offshore Drilling
DO
|
+$1.67M |
| 2 |
Transocean
RIG
|
+$1.5M |
| 3 |
IBM
IBM
|
+$1.37M |
| 4 |
QEP
QEP RESOURCES, INC.
QEP
|
+$1.32M |
| 5 |
Keysight
KEYS
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$5.45M |
| 2 |
Agilent Technologies
A
|
+$1.16M |
| 3 |
DNOW Inc
DNOW
|
+$584K |
| 4 |
Automatic Data Processing
ADP
|
+$491K |
| 5 |
Pfizer
PFE
|
+$237K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.54% |
| 2 | Healthcare | 21.6% |
| 3 | Energy | 16.6% |
| 4 | Technology | 16.23% |
| 5 | Consumer Staples | 8.32% |
Similar funds
CFS
SVWA
SAS
LYV
TAT
NAP
OAMU
TCM
Thompson Rubinstein Investment Management's Q4 2014 Portfolio in Review
As of Q4 2014, Thompson Rubinstein Investment Management held 75 positions worth $261M, up 2.7% from $254M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Thompson Rubinstein Investment Management's Q4 2014 filing shows 5 new, 17 increased, 28 reduced and 1 closed positions. Its largest new stake was Keysight: 36,115 shares worth $1.22M. The largest sale was Edwards Lifesciences, an estimated $5.45M.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Energy.
- Thompson Rubinstein Investment Management's largest Q4 2014 buy was Keysight: 36,115 shares worth $1.22M.
- Thompson Rubinstein Investment Management added most to Diamond Offshore Drilling in Q4 2014, an estimated $1.67M increase.
- Thompson Rubinstein Investment Management's biggest Q4 2014 reduction was Edwards Lifesciences, cutting an estimated $5.45M.
- Thompson Rubinstein Investment Management fully exited DNOW Inc in Q4 2014, selling an estimated $584K.
- Thompson Rubinstein Investment Management's ten largest holdings make up 39% of its $261M portfolio in Q4 2014.
- Thompson Rubinstein Investment Management opened 5 new positions and closed 1 in Q4 2014.
- Thompson Rubinstein Investment Management's portfolio value rose 2.7% quarter-over-quarter to $261M.
Based on Thompson Rubinstein Investment Management's 13F filing for Q4 2014, filed 21 Jan 2015.